Lightstone Ventures — Full Portfolio

Shoulder Innovations develops InSet® glenoid technology for shoulder joint implants that reduce the rocking horse effect and provide mechanical stability, serving patients with severe shoulder arthritis.

HardwareHealthtechMedical DevicesNorthern California, US

Robert Ball(CEO & Executive Chairman)MAMatthew Ahearn(Chief Operating Officer)inJPJeff Points(Executive Officer)inDBDavid Blue(Executive Officer)inDon Running(Manager and Chief Executive Officer)Jeff Ondrla(Chief Technology Officer)

Board seatMCMike Carusi· per SEC Form D

Co-investorsAPAPERTURE Venture PartnersARArboretum VenturesGEGenesis Innovation GroupGLGlobal BrainINInvest MichiganUSUS Venture Partners+2 more

Verastem Oncology is a biopharmaceutical company that discovers and develops drugs to treat cancer patients.

BiotechMedical DevicesNeedham, US

RWRobert WeinbergRICHARD ALDRICH(Director)ACAMY C. CAVERS(Executive Officer)inCCCATHY CAREW(Executive Officer)inJPJONATHAN PACHTER(Executive Officer)inRGROB GAGNON(Executive Officer)in

Co-investorsBEBessemer Venture PartnersCACardinal PartnersFOForesite CapitalLOLongwood FundOBOberland CapitalOROrbiMed

Contego Medical develops the Neuroguard IEP System, a 3-in-1 carotid stenting device combining a carotid stent, dilation balloon, and integrated embolic protection with a 40-micron filter to reduce stroke and cognitive impairment from microembolization.

HardwareHealthtechMedical DevicesRaleigh, US

RSRavish Sachar(CEO & Founder)Paul Sanders(Chief Operating Officer)

Board seatHanson S. Gifford· per SEC Form D

Co-investorsHAHatteras Venture PartnersAMAmzak HealthMOMountain Group CapitalUSUS Venture Partners

PsiThera is a biotechnology company using computational and physics-based methods—including quantum mechanics, molecular dynamics, machine learning, and simulation—for mechanism-driven drug design and discovery.

AI & Machine LearningBiotechDeep Tech

Co-investorsSASamsara BioCapital

Vesper Medical develops a modular venous stent portfolio designed to address the anatomical challenges of the iliac and femoral veins for treating deep venous disease.

HealthtechMedical DevicesWayne, US

BJBruce J. Shook(President and CEO)MKMonica Klos(Executive Officer)inNeil Hattangadi(Director)inPeter Schneider(Director)Mark Garcia(Director)Dennis W. Wahr(Director)

Co-investorsNENew Enterprise Associates (NEA)GIGilde HealthcareVEVensana Capital41415 Capital

Allay Therapeutics develops localized pain management technology designed to deliver several weeks of post-surgical pain relief.

BiotechHealthtechMedical DevicesSan Jose, US

AGAdam Gridley(Executive Officer, Director)inKristen Howells(Executive Officer)inJosh Makower(Director)Tak Cheung(Director)inKarun D. Naga(Executive Officer, Director)

BoardLeighton Read(Director)

Board seatMichael A. CarusiHanson S. Gifford· per SEC Form D

Co-investorsARArboretum VenturesNENew Enterprise Associates (NEA)SGSGInnovateCLClavystBio

Apreo Health develops a bronchoscopic treatment for severe emphysema using a self-expanding airway scaffold designed to reduce trapped air and improve lung function.

BiotechHealthtechMedical DevicesMenlo Park, US

Karun Durgam Naga(Executive Officer, Director)

BoardHanson S. Gifford III(Director)ZSZack Scott(Director)inDFDrew Field(Director)inDMDennis McWilliams(Director)in

Board seatHanson S. GiffordMichael A. Carusi· per SEC Form D

Co-investorsF-F-Prime CapitalINIntuitive VenturesNONorwest Venture Partners

Cala Health develops non-invasive prescription therapies for movement disorders, starting with a treatment for hand tremor and essential tremor.

Deep TechDigital HealthHealthtechMedical DevicesSilicon Valley, US

KRKate Rosenbluth, PhD(President & Chief Innovation Officer)KRKate Rosenbluth(Founder)inDHDeanna Harshbarger(Chief Executive Officer)in

Board seatMichael A. Carusi· per SEC Form D

Co-investorsALAlumni VenturesASAscension VenturesGLGlobal BrainGVGV (Google Ventures)LULux CapitalOSOSF Ventures+3 more

FemTechHealthtechMedical DevicesRedwood City, US

Christopher Owens(Executive Officer, Director)Darrin Uecker(Executive Officer, Director)

BoardKen Haas(Director)Jonathan MacQuitty(Director)inDoug Fisher(Director)

Board seatMCMike Carusi· per SEC Form D

Co-investorsAMAmzak HealthBABain Capital Life SciencesENEndeavour VisionFEFemHealth VenturesKAKaiser Permanente VenturesKLKluz Ventures+5 more

Imperative Care develops medical technologies for treating stroke and other vascular diseases, aiming to address gaps across the patient care journey.

HealthtechMedical DevicesCampbell, US

Farhad Khosravi(Executive Officer, Director)MGMatthew Garrett(Executive Officer)inCharles Alpuche(Executive Officer)SEScott Elliott(Executive Officer)in

BoardJames Rogers(Director)SEStacy Enxing Seng(Director)

Board seatHenry Albert Plain, Jr.· per SEC Form D · $100M raise · filed Mar 2026

Co-investorsASAscension VenturesBABain Capital Life SciencesCACatalio Capital Management, LPDEDelos CapitalFEFemHealth Ventures

Nuvaira develops the dNerva Lung Denervation System, a catheter-based device used in a one-time, outpatient bronchoscopic procedure that disrupts pulmonary nerve input to treat chronic obstructive pulmonary disease (COPD).

HardwareHealthtechMedical DevicesMinneapolis, US

Martin Mayse(Founder)inSDSteve Dimmer(Founder)inDWDennis Wahr(President & CEO)inLFLisa Flaherty(Chief Strategy Officer)inSSSteve Sathre(Vice President of Finance)inSteve Paidosh(Vice President of Operations)

Board seatMichael A, CarusiHenry PlainMichael A. CarusiMCMike CarusiHPHank Plain· per SEC Form D

Co-investorsWIWindham Capital PartnersMOMorgenthalerQIQiming Venture Partners

HealthtechBelmont, US

Barry Cheskin(Executive Officer, Director)S. Arieh Zak(Executive Officer)George Green(Executive Officer)

BoardDrew Schiff(Director)Lou Bock(Director)

Board seatMichael Carusi· per SEC Form D

Co-investorsAIAisling CapitalARArcher Capital GroupARArcher Venture CapitalJOJohnson & Johnson Innovation – JJDCSCScale Venture Partners

Reprieve Cardiovascular develops a decongestion management system that uses real-time patient data to guide and personalize diuretic therapy for fluid removal in heart failure patients.

Digital HealthHealthtechMedical DevicesMilford, US

TFTony Fields(Executive Officer)ABAdam Bartnik(Executive Officer)inMark Pacyna(Executive Officer, Director)inJim Dillon(Executive Officer, Director)Hanson S. Gifford III(Director)Gregory W Mann(Executive Officer)

Board seatHanson S. Gifford· per SEC Form D

Co-investorsARArboretum VenturesRERex Health VenturesDEDeerfield Management CompanyGEGenesis Venture CapitalSASante Ventures

Tangible Science develops contact lens solutions designed to improve comfort and durability for wearers and to provide eye care professionals with more effective treatment options.

HealthtechMedical DevicesMenlo Park, US

KHKaren Havenstrite(Director)inVMVictor McCray(Executive Officer, Director)

BoardDCDouglas Crawford(Director)inHanson Gifford(Director)Chip Heath(Director)Brandon Felkins(Director)

Board seatHanson S. Gifford· per SEC Form D · $4.6M raise · filed Nov 2016

Co-investorsMIMission BiocapitalSHShangBay Capital LLC

Twelve transforms CO2 into chemicals, fuels, and materials through carbon transformation technology.

Advanced ManufacturingCleantechClimate TechHealthtechNew MaterialsMoses Lake, US

NFNicholas Flanders(Founder & CEO)inECEtosha Cave(Founder)inKendra Kuhl(Founder)inACAndrew Cleeland(Executive Officer, Director)in

BoardMarc-Henri Galletti(Director)Nimesh Shah(Director)

Board seatHanson S. GiffordHenry A. Plain, Jr.· per SEC Form D

Co-investorsBRBreakout VenturesDCDCVC (Data Collective)DODolby Family VenturesFIFifth WallADAdvantage Partners Inc.AEAera VC+16 more

65LAB accelerates drug discovery and therapeutic company formation by connecting academic research institutions, life science investors, and Evotec to develop novel medicines into commercial entities.

BiotechDeep TechSingapore, SG

BoardSteve Courtney(Expert in Residence)

Co-investorsCLClavystBioLELeaps by Bayer

A pharmaceutical company that develops medicines and vaccines for patients globally.

BiotechHealthtechMedical DevicesCambridge, US

WYLIE W. VALE(Director)JKJOHN KNOPF(Executive Officer, Director)STEVEN ERTEL(Executive Officer)RSROBERT STEININGER(Executive Officer)inKEVIN F. MCLAUGHLIN(Executive Officer)inMLMATTHEW L. SHERMAN(Executive Officer)

Co-investorsBEBessemer Venture PartnersFOForesite CapitalLOLowercarbon CapitalSOSofinnova VenturesVEVenrockCOCollaborative Fund

Alchemab operates a platform that identifies novel drug targets and therapeutics by analyzing patient antibody repertoires using deep B cell sequencing and computational analysis of samples from disease-resilient individuals.

AI & Machine LearningBiotechDeep TechHealthtech

JOJane Osbourn(Chief Executive Officer)

Co-investorsSVSV Health InvestorsDCDCVC BioRARA CapitalDEDementia Discovery FundONOno Venture Investment, Inc.BRBritish Business Bank+2 more

Amber Therapeutics develops medical technology focused on treating mixed urinary incontinence, advancing toward pivotal clinical trials in the US with expanded feasibility studies in Europe.

Medical Devices

Co-investorsF-F-Prime CapitalINIntuitive VenturesNENew Enterprise Associates (NEA)OXOxford Science Enterprises

Atsena Therapeutics is a clinical-stage gene therapy company developing treatments for inherited retinal diseases that cause vision loss.

BiotechDeep TechMedical DevicesAustin, US

Co-investorsHAHatteras Venture PartnersSOSofinnova Ventures

BiotechTV is a media outlet producing video shows, event coverage, and news focused on the biotech and healthcare sectors, including topics like venture funding, oncology conferences, and drug development.

BiotechMedia & Entertainment

BLBrad Loncar(Founder)in

Bonito develops encoded library and live-cell selection technologies to discover delivery ligands, generating high signal-to-noise data on membrane-bound targets to train AI models for precision drug delivery.

AI & Machine LearningBiotechDeep Tech

RWRichard Wagner(CEO, Cofounder)in

Co-investorsJAJAZZ Venture Partners

Cardiac Booster develops cardiac support technology for use in treating heart conditions.

BiotechHardwareHealthtechMedical DevicesGalway, IE

FLFlorian Ludwig(CEO)inGKGerard Kilcommins(COO)Greg Mann(CFO)PGPatrick Griffin(VP Technology Development)inJGJeff Grainger(VP of Legal Affairs)DMDaragh Moloney(HR Director)in

Co-investorsASAscension Ventures

Carrick Therapeutics is a biopharmaceutical company with a leadership team experienced in oncology drug development and commercialization.

BiotechDigital HealthHealthtechMedical DevicesBoston, US

TPTimothy Pearson(CEO)ABAsh Bahl(CSO)inJHJenny Horsfield(CBO)inSMStuart McIntosh(CMO)inDSDavid Sutherland(VP Finance & Controller)

Co-investorsARARCH Venture PartnersB B Capital GroupB4B4 CapitalCACambridge Innovation Capital

BiotechCambridge, US

Jill C. Milne(Executive Officer, Director)inIan Sanderson(Executive Officer)in

BoardRon Laufer(Director)Nicholas Galakatos(Director)JGJean George(Director)Michael Ross(Director)

Co-investorsCLClarus

Catamaran Bio develops allogeneic CAR-NK cell therapies for cancer treatment, focusing on solid tumors, by combining natural killer (NK) cell biology with synthetic biology and non-viral cell engineering.

BiotechHealthtech

BMBranden Moriarity(Scientific Co-founder)Catherine Bollard(Scientific Co-founder)

Co-investorsASAstellas Venture Management LLCSOSofinnova Partners

Cerevance develops precision novel therapeutics for central nervous system disorders, particularly neurodegenerative diseases, using its proprietary NETSseq platform and machine learning to identify targets from an extensive collection of human brain tissue samples.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesBoston, US

CTCraig Thompson(Chief Executive Officer)inSVSagar Vaidya(Chief Medical Officer)inCarrie Ann Cook(Chief Business Officer)MCMark Carlton(Chief Scientific Officer)inOVOttavio V. Vitolo(Chief Medical Officer)in

Co-investorsFOForesite CapitalGVGV (Google Ventures)DEDementia Discovery FundSVSV Life SciencesDEDementia DiscoverySVSV Health Investors+3 more

HealthtechSanta Rosa, US

Fred Khosravi(Director)Tony Fields(Executive Officer)

BoardJames Eadie(Director)APAzin Parhizgar(Executive Officer, Director)inHenry A. Plain(Director)Leo Nelson Hopkins(Director)

Co-investors41415 CapitalEAEaston CapitalMOMorgenthaler

CoolSculpting offers FDA-cleared body-contouring procedures that use controlled cooling to reduce visible fat bulges in areas such as the chin, abdomen, thighs, and flanks, along with the CoolTone device for muscle strengthening and toning.

HealthtechMedical DevicesWellness & Fitness

Co-investorsAIAisling Capital

Crystalys Therapeutics is a clinical-stage biopharmaceutical company developing targeted therapies for gout, a chronic metabolic disease caused by elevated uric acid.

BiotechHealthtechMedical DevicesSan Diego, US

JMJames Mackay(President & Chief Executive Officer)inNihar Bhakta(Chief Medical Officer)inAshwin Ram(Chief Operating Officer)inDeAnne Reid(Chief Administrative Officer)in

Co-investorsCACatalys PacificNONovo HoldingsANAN Venture PartnersFRFrazier Life SciencesLOLongwood Fund

Curie.Bio is a biotech venture firm pairing seed capital with in-house drug discovery support for therapeutics founders.

ZWZach Weinberg(Founder)in

Co-investorsALAlleyCorpARARCH Venture PartnersDNDNA CapitalF-F-Prime CapitalGVGV (Google Ventures)SHShine Capital+1 more

Cyteir is a clinical-stage oncology company developing CYT-0851, an oral investigational drug that inhibits monocarboxylate transporters.

BiotechHealthtechCambridge, US

Kevin Mills(Executive Officer, Director)inRGRonald Goldstein(Executive Officer)inDCDonald Corcoran(Executive Officer, Director)inMRMarkus Renschler(Director)in

BoardTimothy Romberger(Director)Barry Mills(Director)

Co-investorsDRDroia VenturesOUOUP (Osage University Partners)ALAlly Bridge GroupJAJanus Henderson InvestorsNONovo HoldingsOSOsage University Partners+2 more

Earlens makes a hearing aid that vibrates the eardrum directly rather than using speakers to amplify sound, allowing amplification across a broad audible frequency range including higher frequencies for speech understanding.

HardwareHealthtechMedical DevicesMenlo Park, US

Rodney Perkins, M.D.(Director)William M. Facteau(Executive Officer, Director)Bernard Shay(Executive Officer)Phil Lyons(Executive Officer)BEBrent Edwards(Executive Officer)Greg Koskowich(Executive Officer)

Co-investorsAIAisling CapitalNENew Enterprise Associates (NEA)WIWindham Capital PartnersMOMorgenthalerSISightLine Partners

EndoGastric Solutions offers the Transoral Incisionless Fundoplication (TIF 2.0) procedure and the EsophyX device used to treat GERD, along with reimbursement and technical/administrative support (TAP program) for medical practices.

BiotechHealthtechMedical DevicesSan Mateo, US

Philip Macdonald(Executive Officer)Louis Baldino(Executive Officer, Director)Lilip Lau(Executive Officer)Josh DeFonzo(Executive Officer)in

BoardMCMichael Carusi(Director)inArda Minocherhomjee(Director)

Co-investorsACAccelmed PartnersCACanaan PartnersEVEvidity Health CapitalVCVCFA GroupDEDe Novo VenturesFOFOUNDATION MEDICAL PARTNERS+1 more

FIRE1 develops NORM, an implantable sensor placed in the inferior vena cava to directly measure fluid volume in heart failure patients, paired with a self-management platform to help patients engage with their own care.

Digital HealthHardwareMedical DevicesDublin, IE

Co-investorsANAndera PartnersLOLongitude CapitalNENew Enterprise Associates (NEA)GIGilde HealthcareGIGimvIRIreland Strategic Investment Fund+5 more

Flex Pharma provides accessible generic vasodilator medications, including PDE5 inhibitors, to U.S. patients at lower costs than brand-name alternatives.

BiotechDigital HealthHealthtechMedical Devices

Dr. Rod MacKinnon(Founder)

Co-investorsBEBessemer Venture PartnersECEcoR1 CapitalLOLongwood Fund

Hydra provides analytics query execution for Postgres databases with separated compute resources, automatic scaling, and built-in caching, designed for time series and event data workloads across multiple deployment environments.

Data & InfrastructureDeveloper ToolsEnterprise SoftwareSan Francisco, US

JSJoseph Sciarrino(Founder)in

Co-investorsY Y Combinator1010x FoundersCOComcast VenturesEREra FundsFLFlume VenturesFOFounders Fund+5 more

BiotechCambridge, US

Magdalene Moran, Ph.D.(Executive Officer)Bert Chenard, Ph.D.(Executive Officer)Russell Herndon(Executive Officer, Director)Tom Burke(Executive Officer)

BoardVincent Miles(Director)JGJean George(Director)

Co-investorsNENew Enterprise Associates (NEA)ABAbingworthLILilly Ventures

Medisix Therapeutics develops a pipeline of therapeutic products using integrated technology platforms spanning the product lifecycle, supported by a CMC platform for large-scale manufacturing.

BiotechHealthtechSingapore, SG

PDProfessor Dario Campana, MD, PhD(Scientific Founder)Andrew Bruce, BSc(Chief Executive Officer)

Day One (part of Servier) is a biopharmaceutical company developing targeted oncology medicines, with a focus on cancers affecting patients of all ages, including pediatric low-grade glioma (pLGG).

BiotechHealthtechCambridge, US

MICHAEL J. KAUFMAN(Executive Officer)inDonald Bergstrom(Executive Officer)inAPANNA PROTOPAPAS(Executive Officer, Director)TLTimothy Lowinger(Executive Officer)Eva Jack(Executive Officer)Wayne Foster(Executive Officer)

Co-investorsBABain Capital Life SciencesF-F-Prime CapitalNENew Enterprise Associates (NEA)NENextech InvestPFPfizer Venture InvestmentsRHRho Ventures

Terumo Neuro (formerly MicroVention) develops minimally invasive catheter-based medical devices for treating neurovascular disorders including cerebral aneurysms, ischemic stroke, carotid artery disease, and neurovascular malformations.

Enterprise SoftwareHealthtechMedical DevicesAliso Viejo, US

CSCarsten Schroeder(President and CEO)in

HealthtechFremont, US

Anton Clifford(Executive Officer)inJLJames Leech(Executive Officer)inCGChristopher Gleason(Executive Officer)inKevin K. Sidow(Executive Officer, Director)

BoardJoshua Makower(Director)SMShahzad Malik(Director)in

Co-investorsNENew Enterprise Associates (NEA)RURunway Growth CapitalADAdvent Life SciencesGBGBS Venture Partners Ltd.GIGilde HealthcareVEVertex Ventures HC

Portola develops research and investigates new targets, modalities, and technologies to address rare disease challenges for patients and their families.

BiotechDigital HealthHealthtechMedical Devices

Co-investorsKHKhosla VenturesNFNFDG

ProVerum is a venture-backed medical device startup developing minimally invasive technologies to treat benign prostatic hyperplasia (BPH).

HardwareHealthtechMedical DevicesDublin, IE

Dr Conor Harkin(Founder)inRNRíona Ní Ghriallais(Founder)in

Co-investorsATAtlantic Bridge VenturesOROrbiMedIRIreland Strategic Investment FundMVMVM Life Science Partners

UCB is a global biopharmaceutical company that develops medicines and treatment-support services for people living with neurological and autoimmune conditions, including rare diseases such as epilepsy.

BiotechHealthtechCambridge, US

Douglas A. Treco(Executive Officer, Director)Kerry Black(Executive Officer)in

BoardEdward Mathers(Director)RSRajeev Shah(Director)inPeter Bisgaard(Director)Jason Lettman(Director)

Co-investorsNENew Enterprise Associates (NEA)RARA Capital

Relievant offers the Intracept Procedure, a minimally invasive, FDA-cleared medical intervention designed to relieve chronic low back pain caused by vertebrogenic pain.

Medical DevicesRedwood City, US

Alex DiNello(Executive Officer, Director)

BoardRichard Mott(Director)JKJustin Klein(Director)inBABrent Ahrens(Director)inJason Lettman(Director)John Ryan(Director)

Co-investorsCACanaan PartnersEMEmergent Medical Partners, LLPNENew Enterprise Associates (NEA)MOMorgenthalerVEVensana Capital

Co-investorsLILifeforce CapitalPFPfizer Venture InvestmentsDIDigitalis VenturesMOMorgenthalerRORoche Venture FundSRSR One Capital Management

SetPoint Medical develops an FDA-approved implantable neurostimulation device that stimulates the vagus nerve to reduce inflammation, offering a device-based treatment for adults with moderate-to-severe rheumatoid arthritis who have not responded to biologic or targeted synthetic drugs.

BiotechHealthtechMedical DevicesValencia, US

MSMurthy Simhambhatla(CEO)inDCDavid Chernoff(Chief Medical Officer (MD))YLYaakov Levine(PhD)inRSRohan Seth(Executive Officer)in

BoardBWBlake Wu(Director)inJMJuan-Pablo Mas(Director)in

Co-investorsALAlly Bridge GroupNENew Enterprise Associates (NEA)NONorwest Venture PartnersTOTopspin PartnersCACatalio Capital Management, LPCICitta Capital+5 more

Tagworks Pharmaceuticals develops cancer therapies using its Click-to-Release platform, a chemical reaction that activates antibody-drug conjugates (ADCs), masked immunomodulators, and other prodrugs on-target while deactivating radioimmunotherapies off-target.

BiotechHealthtechMedical DevicesNijmegen, NL

Co-investorsBIBifNENew Enterprise Associates (NEA)NONovartis Venture FundYSYsios CapitalCLClarus VenturesGIGilde Healthcare+1 more

Tallac Therapeutics is a clinical-stage biopharmaceutical company developing oligonucleotide-based antibody conjugates (TRAAC candidates) designed to deliver immune-activating agents to tumor microenvironments for oncology indications.

BiotechHealthtechMedical DevicesBurlingame, US

HWHong Wan(Executive Officer, Director)in

BoardRan Geng(Director)Michael Carusi(Director)Isaac Cheng(Director)Christine Brennan(Director)CGCorey Goodman(Director)in

Co-investorsMRMRL Ventures FundVEvenBio PartnersMAMatrix Partners ChinaVEvenBio Global Strategic

The Foundry is a medical device incubator that identifies unmet clinical needs and builds companies around new technologies to address them, working with physician collaborators to develop products from concept to market.

BiotechDeep TechHealthtechMedical Devices

Co-investorsNENew Enterprise Associates (NEA)OAOasis Capital

Tizona Therapeutics is a biotechnology company developing first-in-class immuno-oncology therapeutics, including its lead clinical-stage asset TTX-080, aimed at changing cancer progression and relapse.

AI & Machine LearningBiotechHealthtech

VKVijay K. Kuchroo(Scientific Co-Founder & Advisory Board Member)Drew Pardoll(Scientific Co-Founder & Advisory Board Member)Dario Vignali(Scientific Co-Founder & Advisory Board Member)Jedd Wolchok(Scientific Co-Founder & Advisory Board Member)COChristine O'Brien(Chief Executive Officer & Board Member)inCBCourtney Beers(Chief Scientific Officer)

Co-investorsCACanaan PartnersMPMPM BioImpactABAbingworthGIGilead SciencesASAstellas Venture Management LLC

Trishula Therapeutics is a clinical-stage biopharmaceutical company developing TTX-030, a first-in-class anti-CD39 antibody for advanced cancers.

BiotechHealthtech

ASAnil Singhal(President and CEO)inSMSiddhartha Mitra(Chief Medical Officer)in

Co-investorsCACanaan PartnersMPMPM BioImpactASAstellas Venture Management LLC

San Diego biotech founded in 2019 developing oral anti-inflammatory small molecules targeting RNA binding proteins.

Co-investorsARARCH Venture PartnersMEMedical Excellence Capital

Urotronic develops drug-coated balloons for interventional urology, including the Optilume products for treating benign prostatic hyperplasia (BPH) and urethral strictures.

HealthtechMedical DevicesPlymouth, US

Junfeng Wang(Director)David Perry(Executive Officer, Director)Tan Ching(Director)Hui Hu(Director, Promoter)Lixiao Wang(Director, Promoter)Doug Kohrs(Director)

Co-investorsHMHM Venture PartnersENEnterprise IrelandGIGilde HealthcareIRIreland Strategic Investment FundLELegend CapitalMVMVM Life Science Partners+1 more

An R&D-driven biopharmaceutical company that uses AI to develop breakthrough medicines and vaccines focused on immune system disorders across five therapeutic areas.

AI & Machine LearningBiotechMedical DevicesCambridge, US

IMIvana Magovcevic-Liebisch(Executive Officer, Director)CVChristopher Verni(Executive Officer)inMary Thistle(Director)Evan Thackaberry(Executive Officer)Suzanne Bruhn(Director)Gerhard Koenig(Director)

Co-investorsATAtlas VentureVIVida VenturesHAHatteras Venture PartnersLOLongwood Fund

Nimbus Therapeutics is a biotechnology company that designs precision small molecule medicines using a computational, multidisciplinary drug discovery approach.

AI & Machine LearningBiotechDeep TechHealthtech

Co-investorsATAtlas VenturePFPfizer Venture Investments

Medical Devices

Co-investorsVEVensana Capital

Willow (originally founded as Contento) offers social media management for small and medium-sized B2B professional service providers, combining a scheduling and content platform with AI tools and human social media coaching.

AI & Machine LearningEnterprise SoftwareMarketing TechSaaSGhent, BE

LDLudwig Dumont(Founder)in

Co-investorsPMPMVSMSmartFinHEHetz VenturesMEMeritech Capital PartnersNENew Enterprise Associates (NEA)